CA
NZ
UK
AU
IND
US
Honeywell Aerospace (NASDAQ: HONA) reported disappointing second-quarter results on August 5, 2026, leading to a significant 19.4% drop in its stock price to $164.24. The company generated $4.5 billion in sales, marking a 5% increase in organic sales year-over-year. Analysts viewed this as a …
Power Solutions International, Inc. (NASDAQ: PSIX) reported quarterly sales of $152.5 million, a decrease of 21% compared to the same period last year. Despite the decline in sales, Power Solutions International beat earnings expectations with $0.73 diluted EPS, compared to a consensus estimate of …
Century Aluminum reported earnings per share of $2.39 for the quarter ended June 30, 2026, surpassing consensus expectations. Adjusted EBITDA rose to $326.9 million, and net sales increased to $752.1 million. The market responded positively to the results.
Capital Bancorp, Inc. filed its Form 10-Q with the SEC for the quarterly period ended June 30, 2026, reporting net income, balance sheet growth, and key earnings-per-share figures for both the second quarter and first half of the year.
Mechanics Bancorp filed its Form 10-Q for the quarterly period ended June 30, 2026 with the Securities and Exchange Commission on August 7, 2026, reporting consolidated financial results following the September 2, 2025 merger of HomeStreet Bank with and into Mechanics Bank.
PAMT Corp filed its Form 10-Q with the SEC for the quarterly period ended June 30, 2026, reporting continued operating losses and a decline in cash and total assets from year-end 2025 levels.
Cimpress plc filed its Annual Report on Form 10-K with the U.S. Securities and Exchange Commission on August 7, 2026, covering the fiscal year ended June 30, 2026, and reporting $3.7 billion in revenue for the period.
This strong performance, which included first half 2026 revenue growth of 60%, has led the medical technology company to increase its full year 2026 net revenue guidance to a range of $67 million to $69 million. The revised outlook represents approximately 42% to 46% …
SpyGlass Pharma posted a net loss of $19.9 million, or $0.59 per share, for the quarter ended June 30, a sharp increase from the $8.7 million loss a year earlier. Earnings per share came in at $‑0.69 versus a consensus estimate of $‑0.51, underscoring …
Tandem Diabetes Care, Inc. (NASDAQ: TNDM) reported a net loss of $21.2 million for the second quarter ending June 30, 2026, marking a significant recovery from the previous year's loss of $52.4 million. The earnings per share (EPS) came in at $-0.31, beating a …
Please wait processing your request...